Why L-theanine and caffeine are so often taken together

August 13, 2026

Tea carries two active compounds at once, and the supplement industry has spent twenty years reproducing the combination in a capsule. This is what has been measured in healthy adults, which trials failed, and how large the effects are at their real size.

A compound found in a shade-grown tea

In 1949 the Japanese chemist Yajiro Sakato isolated an unfamiliar amino acid from gyokuro, a green tea grown under shade cloth for several weeks before picking. He named it theanine.

Shading matters to the story. It raises the leaf's theanine content, because the compound is made in the root and broken down in the light — which is why the most theanine-rich teas are also the most expensive.

Everything below is downstream of a farming practice that predates the chemistry by centuries.

Close crop, loose green tea leaves in a shallow ceramic dish on a worn wooden counter, morning window light from the side, matte cream background

Figure 1 Isolated from a tea grown deliberately in the shade Theanine was first isolated from gyokuro in 1949. The shading period before harvest raises the leaf's theanine content, and also makes the tea costly. Sakato, 1949, Journal of the Agricultural Chemical Society of Japan. Illustrative photograph.

What the molecule is

A near-copy of something the body already uses

L-theanine is N-ethyl-L-glutamine — glutamine with an ethyl group attached. That structural resemblance to glutamate and glutamine is the reason it gets discussed alongside brain chemistry at all.

Where it occurs

Almost entirely in the tea plant, Camellia sinensis. The one well-documented exception outside tea is a mushroom: theanine was identified in the bay bolete by Casimir and colleagues (Biochimica et Biophysica Acta, 1960).

Nobody is getting it in quantity from a mixed diet. Tea is the dietary source, and that is the list.

Why the pairing exists at all

Nobody invented it. Tea already contains caffeine and theanine together, and the research question came from the drink rather than the other way round.

The hypothesis was narrow: whether tea's second compound changes what its first one does. That is a smaller question than "does this improve thinking", and the two are worth keeping apart.

Simple two-part composition diagram, cream ground, forest-green line work, one leaf outline resolving into two labelled compound blocks, flat, no icons, generous white space

Figure 2 The combination came from the leaf, not from a laboratory Brewed tea delivers caffeine and theanine in the same cup. The trials below were built to ask what the second compound does to the first. Illustrative diagram of tea leaf composition.

What the trials actually measure

Not concentration, which cannot be measured directly. They use timed computer tasks — switching between two rules, or holding a target in mind while distracting information is shown alongside it.

Those tasks are reasonable proxies. They are not a working afternoon, which no laboratory has found a way to score.

The results that started it

Two compounds, four conditions

Haskell and colleagues gave 250 mg of L-theanine, 150 mg of caffeine, both, or placebo, in a double-blind crossover (Biological Psychology, 2008; n=27, healthy adults, single doses). The combination improved speed and accuracy on attention-switching and reduced susceptibility to distracting information. Theanine alone did much less.

Smaller amounts, similar direction

Owen and colleagues used 97 mg of theanine with 40 mg of caffeine — closer to a strong cup of tea — and reported improved accuracy on attention-switching and less susceptibility to distraction (Nutritional Neuroscience, 2008; n=27, healthy adults).

Giesbrecht and colleagues repeated that pairing and reported improved alertness and less self-rated tiredness (Nutritional Neuroscience, 2010; n=29, healthy adults).

Read those three honestly before going further

All three are single-dose studies in fewer than thirty people, measuring lab tasks in the ninety minutes after swallowing. None followed anyone for a week.

That is not a criticism of the researchers. It is the normal shape of acute cognitive work, and it caps what the work can support.

Horizontal bar chart, five short bars of similar length, cream ground, forest-green bars, values labelled at bar ends, no gridlines, wide margins

Figure 3 Every trial in this literature is small Participant numbers across the main studies: 27, 27, 29, 20, 48. Effects found in groups this size are real findings and weak evidence at once. Haskell 2008 · Owen 2008 · Giesbrecht 2010 · Dodd 2015 · Rogers 2008.

The trials that did not find it

The combination that was not separable from caffeine

Dodd and colleagues tested 50 mg of theanine, 75 mg of caffeine and the pair against placebo (Psychopharmacology, 2015; n=20, healthy adults, single doses). Caffeine improved alertness and task performance. The combination was not clearly distinguishable from caffeine alone.

The trial where theanine may have worked against it

Rogers and colleagues used 200 mg of theanine with 100 mg of caffeine (Psychopharmacology, 2008; n=48, healthy adults). They found little evidence that adding theanine improved on caffeine for alertness or performance, and some indication that it blunted caffeine's effects.

The result that had nothing to do with attention

That same trial's clearest finding was cardiovascular: theanine reduced the rise in blood pressure caffeine produced. A modest, specific observation, and the one in this literature with least to do with why people buy the pairing.

A page that cites the first three studies and omits these two is not reporting a literature. It is quoting the half that sells.

Two-column dot plot, five dots split between a left and right column, cream ground, forest-green marks, thin dividing rule, no gridlines

Figure 4 The literature splits Three of the main acute trials reported attention benefits for the combination. Two found effects that were not separable from caffeine alone. Haskell 2008, Owen 2008 and Giesbrecht 2010 against Dodd 2015 and Rogers 2008.

The five trials side by side, and what a review made of them

Study	Participants	Amounts given	Reported
Haskell 2008, Biological Psychology	27 healthy adults	250 mg theanine, 150 mg caffeine	Improved attention-switching; less distraction
Owen 2008, Nutritional Neuroscience	27 healthy adults	97 mg theanine, 40 mg caffeine	Improved accuracy on attention-switching; less tiredness
Giesbrecht 2010, Nutritional Neuroscience	29 healthy adults	97 mg theanine, 40 mg caffeine	Improved alertness, reduced tiredness
Dodd 2015, Psychopharmacology	20 healthy adults	50 mg theanine, 75 mg caffeine	Combination not separable from caffeine alone
Rogers 2008, Psychopharmacology	48 healthy adults	200 mg theanine, 100 mg caffeine	No additive benefit; theanine reduced caffeine's blood-pressure rise

Camfield and colleagues gathered the acute studies of tea constituents and concluded that caffeine and theanine together affect attention measures, while noting how much the doses and tasks varied between studies (Nutrition Reviews, 2014; systematic review).

A review inherits the weaknesses of what it reviews. Small acute trials summarised carefully are still small acute trials.

Theanine on its own, over weeks

One frequently cited trial gave 200 mg a day for four weeks in a placebo-controlled crossover with a two-week washout, reporting improvements on stress, sleep-quality and verbal-fluency measures (Hidese et al., Nutrients, 2019; n=30, mean age 48).

Two disclosures that belong beside it

The paper states that it was funded by the company that supplied the theanine, and that two authors were employees of that company. It is disclosed in the paper, which is how disclosure is meant to work.

The authors also note that only about a fifth of the variables measured changed significantly against placebo. When a study measures many things, some separate by chance — and the paper says so.

Grid of twenty small squares, four of them filled forest-green and the rest outlined only, cream ground, flat, no labels inside the squares

Figure 5 Roughly one measure in five moved In a four-week trial of 200 mg a day, about 20% of measured variables changed significantly against placebo — a limitation the authors state themselves. Hidese et al., Nutrients, 2019 · n=30 · 200 mg/day · 4 weeks · sponsor-funded.

The brainwave claim, at its real weight

Marketing copy often reaches for an EEG result: that theanine increases alpha-band activity, a pattern associated with relaxed wakefulness. The usual source is a short report in a conference supplement (Nobre et al., Asia Pacific Journal of Clinical Nutrition, 2008).

Take the finding, then look at what it is. A change in an EEG band is not a change in performance, and a conference supplement is not a full peer-reviewed paper.

Close crop, a single EEG trace printed on paper, shallow depth of field, forest-green ink on cream stock, raking daylight

Figure 6 A waveform is a measurement, not an outcome Alpha-band activity is associated with relaxed wakefulness. Showing that a compound shifts it does not establish that anything a person does afterwards is different. Illustrative photograph. Nobre et al., 2008, published in a conference supplement.

How this compares with a cup of tea

Keenan and colleagues measured theanine across commercial teas and brewing methods and found the amount per cup varies substantially with both leaf and preparation (Food Chemistry, 2011).

The point survives without a precise figure: a cup delivers a fraction of the 200 mg used in the trials, alongside caffeine in a ratio the drinker does not set.

Four things this literature does not establish

That the pairing does anything over months. The longest trial ran four weeks and tested theanine alone.
That the ratio matters. The studies used different amounts of both and none set out to compare ratios.
That it offsets a large amount of caffeine. The trials used 40–150 mg, roughly half a mug of coffee to one and a half.
That any of it applies to a specific person. These are group averages from lab sessions.

Horizontal range bar, cream ground, forest-green band spanning a narrow region of a wider axis, two tick labels, no gridlines, flat

Figure 7 The caffeine amounts tested were modest Across these trials caffeine was given at 40 mg to 150 mg. The FDA describes 400 mg a day as not generally associated with dangerous effects in healthy adults. Doses as published in Haskell 2008, Owen 2008, Giesbrecht 2010, Dodd 2015, Rogers 2008. Daily figure per FDA consumer guidance.

The amounts, plainly

Acute trials of the pairing used roughly 50–250 mg of theanine. The four-week trial of theanine alone used 200 mg a day, which is why that figure appears so often on shelves.

A panel establishes which compound is present and in what amount, outside any blend. It cannot say what was measured in whom, which is why the population matters more than the milligram figure — worked through for another ingredient in how much alpha-GPC the research actually used.

Finding the amount takes seconds once the panel's shape is familiar; the sequence is in how to read a Supplement Facts panel in about sixty seconds. What sits beside theanine in a formula is a separate question, covered in what acetylcholine actually does.

Where we stand

Weal Focus contains L-theanine at 200 mg and no caffeine. Anyone who drinks coffee is assembling the pairing themselves, at whatever ratio their morning produces; anyone who does not is taking the compound the four-week trial tested alone.

That is a formulation fact rather than a recommendation, and the trials above are all that stands behind it — including the two that found nothing.

Close crop, a stoneware mug of black coffee beside two white capsules on a kitchen table, morning window light, matte cream background

Figure 8 Two decisions, made separately Caffeine intake and theanine intake are set by different things — one by a drink, the other by a panel. Only the second is printed. Illustrative photograph.

Sources for every figure, with the population studied in each, are on our citations page.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.